Inflammatory cytokines and pyroptosis in Coronavirus infection
Inflammatory cytokines and pyroptosis in Coronavirus infection
批准号:
10171455
负责人:
FABIO C RE
金额:
$42.9万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2023-07-31
关键词:
2019-nCoVAffectAnimal ModelBiologyCOVID-19COVID-19 pandemicCaspaseCell DeathCellsCoronavirusCoronavirus InfectionsCytolysisDevelopmentDinoprostoneDiseaseDisease OutcomeEndothelial CellsEpithelial CellsFeedbackFutureGeneticHomeostasisHumanImmunologic ReceptorsImpairmentInfectionInfection ControlInflammasomeInflammationInflammatoryInflammatory ResponseInterferon Type IInterferonsInterleukin-1 betaInterventionKnock-inKnock-outLeukocyte ElastaseLungLung infectionsMediatingMiddle East Respiratory SyndromeModelingMorbidity - disease rateMouse StrainsMusNeutrophil InfiltrationOrganPathogenesisPathologicPeptide HydrolasesPharmacologyPhaseProductionResistanceRespiratory Tract InfectionsRoleSevere Acute Respiratory SyndromeStructure of parenchyma of lungSyndromeTestingTherapeuticTissuesVaccinesVirusVirus Replicationalveolar epitheliumbasecell typecytokinecytokine release syndromehuman coronavirushuman diseaseimmunopathologyinhibitor/antagonistinsightlung injurymortalitymouse modelneutrophilrespiratory
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
Human Coronaviruses (hCoV) cause severe respiratory syndromes like SARS, MERS, and the ongoing
pandemic of Covid-19 caused by the recently identified SARS-Cov2. Human and murine studies indicate that
excessive inflammation, rather than viral replication, may precipitate these infections into lethal diseases. The
overarching hypothesis of this proposal is that the excessive inflammation and neutrophil recruitment
triggered by IL-1β and pyroptotic cell lysis severely impair the host ability to control infection and maintain
homeostasis. The corollary of this hypothesis, if proven correct, is that carefully timed inhibition of IL-1β,
pyroptosis, and neutrophil proteases should be beneficial to treat Covid-19 and other hCoV infections.
Increasing the significance of our study, these therapies are already approved to treat a number of human
diseases, a fact that bodes well for a rapid approval to treat Covid-19 and other hCoV infections. The mouse
CoV MHV-1 provides an excellent model of CoV lung infections and will be used to test our hypothesis in
these specific aims: AIM 1. Is IL-1β deleterious during CoV infection and through which mechanisms? We will
test the hypothesis that excessive production of IL-1β drives neutrophil recruitment to the infected lung with
consequent tissue damage. The ability of IL-1β to exacerbate the pathogenesis of MHV-1 lung infection will
be studied in susceptible and resistant mouse strains treated with pharmacological inhibitors of IL-1β or in
strains deficient in IL-1β. We will determine whether excessive neutrophil recruitment damages lung tissue
through release of neutrophil elastase. We will also test the hypothesis that IL-1β inhibits type I and type III
IFN production by stimulation of PGE2 synthesis. We will use genetic and pharmacological approaches to
examine how inhibition of PGE2 production affects IFN-I and IFN-III production during MHV-1 infection. We
will test whether interventions to regulate IFN-I or PGE2 in the early or late phases of the infection have
opposite effect on the disease outcome. AIM 2. Is pyroptosis beneficial or deleterious in MHV-1 infection and
which inflammasome triggers cell death? We will test the hypothesis that gasdermin D-dependent pyroptosis
of lung cells may affect pathogenesis of coronavirus infection in opposite ways by either restricting viral
replication or exacerbating inflammation. We will test the hypothesis that pyroptosis of CoV-infected lung
epithelial or endothelial cells is mediated by caspase-11. Mouse strains that lack expression of caspase-11 in
lung epithelial or endothelial cells have been generated in our lab and will be used to test tissue-specific role
of caspase-11 during MHV-1 infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of non-myeloid cells' pyroptosis in melioidosis
-
批准号:10635662
-
项目类别:
-
资助金额:$50.7万
-
财政年份:2023
-
负责人:FABIO C RE
-
依托单位:
Role of neutrophils and elastase in melioidosis
-
批准号:9057949
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2015
-
负责人:FABIO C RE
-
依托单位:
Role of NLRP3-inflammasome in alum's adjuvanticity
-
批准号:8012858
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2010
-
负责人:FABIO C RE
-
依托单位:
Role of NLRP3-inflammasome in alum's adjuvanticity
-
批准号:8206798
-
项目类别:
-
资助金额:$34.41万
-
财政年份:2010
-
负责人:FABIO C RE
-
依托单位:
Role of NLRP3-inflammasome in alum's adjuvanticity
-
批准号:8417705
-
项目类别:
-
资助金额:$32.35万
-
财政年份:2010
-
负责人:FABIO C RE
-
依托单位:
Role of NLRP3-inflammasome in alum's adjuvanticity
-
批准号:8602799
-
项目类别:
-
资助金额:$34.41万
-
财政年份:2010
-
负责人:FABIO C RE
-
依托单位:
Role of NLRP3-inflammasome in alum's adjuvanticity
-
批准号:7897509
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2010
-
负责人:FABIO C RE
-
依托单位:
The NLR-inflammasome as mediator of Alum's adjuvanticity
-
批准号:7499099
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2007
-
负责人:FABIO C RE
-
依托单位:
The NLR-inflammasome as mediator of Alum's adjuvanticity
-
批准号:7358634
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2007
-
负责人:FABIO C RE
-
依托单位:
Multimeric MD-2 as an LPS decoy
-
批准号:6950930
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2003
-
负责人:FABIO C RE
-
依托单位:
Multimeric MD-2 as an LPS decoy
-
批准号:6732625
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:FABIO C RE
-
依托单位:
Multimeric MD-2 as an LPS decoy
-
批准号:6597243
-
项目类别:
-
资助金额:$25.65万
-
财政年份:2003
-
负责人:FABIO C RE
-
依托单位:
海外基金